Leaderboard

Fr | De
Keine Artikel ausgewählt!     Warenkorb  
Sie sind hier: Fachliteratursuche » Leber » Leberzirrhose 14. November 2025
Suchen
Gastroplattform
Leberzirrhose
Erweiterte Suche
Abklärungen / Diagnostik
Therapien
Guidelines
Fortbildung
News / Journalscreening
Fachliteratursuche
Gallenwege
Leber
Hepatitis
Leberzirrhose
Neoplasie
Portale Hypertonie
Anderes
Magen-Darm
Oesophagus
Pankreas
Kongresse / Tagungen
Services / Tools
Links
Rect Top
  Schrift: Schrift grösser Schrift kleiner

   Seite 1 von 1859  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 37175  
   
The Correlation Between the Ratio of ALT to qHBsAg and the Recompensation of HBV-Related Cirrhosis Patients: A Retrospective Cohort Study Based on the Baveno VII Criteria.
Turk J Gastroenterol
Xu Y, Zhang Y, Jiao S, Lin C, Ye Q, Wang Y.
PMID: 41236110 [PubMed - indexed for MEDLINE]


Optimizing clinic consultations in primary biliary cholangitis: International consensus recommendations.
Hepatol Commun
Bantel H, Hirschfield GM, Jones DE, Kowdley KV, Lleo A, Mitchell-Thain R, Moore A, Roberts C, Tanaka A.
PMID: 41235915 [PubMed - indexed for MEDLINE]


Temporal and demographic trends in alcohol-related-cirrhosis, alcohol-related hepatitis, and non-alcohol-related cirrhosis hospitalizations from 2012-2023: A population-based study in Alberta, Canada.
Am J Gastroenterol
Swain LA, Godley J, Wang M, Brahmania M, Abraldes JG, Tang KL, Flemming JA, Pasaraba LJ, Shaheen AA.
PMID: 41235808 [PubMed - as supplied by publisher]


Liver Fibrosis: Interactions Between Cells and Microenvironments.
Turk J Gastroenterol
Zou X, Ke Y, Shao Y, Liu S, Shi T.
PMID: 41235615 [PubMed - indexed for MEDLINE]


Serial Liver Stiffness Measurement and Serum Biomarkers Are Not Strong Predictors of the Regression of Fibrosis among Chronic Hepatitis B Patients Receiving Antiviral Therapy Based on Triple Liver Biopsies.
Gut Liver
Zhang J, Chen S, Zhou J, Wang B, Wu X, Xu X, Zhao X, Kong Y, Ou X, Sun Y, You H.
PMID: 41234032 [PubMed - indexed for MEDLINE]


BIGH3 as a potential biomarker for fibrosis in metabolic dysfunction-associated steatotic liver disease: insights from mouse and human studies.
BMC Gastroenterol
Zhuang Z, Zhuge F, Liu Y, Song Y, Luo Y, Liu J, Yang W, Kong J, Zhang H, Yang J, Shi J.
PMID: 41233721 [PubMed - indexed for MEDLINE]


Identifying SUMOylation-related genes in liver fibrosis with bioinformatics and experimental models for diagnostic insights.
Sci Rep
Su Z, Ding Y, Xue J, Sun J, Ji C.
PMID: 41233500 [PubMed - indexed for MEDLINE]


Fatigue and associated psychosocial factors in patients with liver cirrhosis: prevalence, indicators and course. Results from the EnErGie Study.
Clin Nutr ESPEN
Meyer F, Rischmüller K, Wiese ML, Sautter LF, Esau S, Müller J, Ehlers L, Metges CC, Kropp P, Garbe LA, Aghdassi AA, Lerch MM, Jaster R, Lamprecht G, Valentini L.
PMID: 41232768 [PubMed - as supplied by publisher]


Clinical Perspectives on Long-Term Albumin Therapy in Decompensated Cirrhosis: A Nationwide Delphi Survey in Spain-The ALBA Study.
Liver Int
Fortea JI, Rodríguez DR, Albillos A, Vergés ES, Bañares R.
PMID: 41230825 [PubMed - indexed for MEDLINE]


Allyl nonanoate as a novel bile-derived biomarker in metabolic dysfunction-associated steatotic liver disease.
Front Endocrinol (Lausanne)
Lee SH, Kim J, Lee SR, Lee BS, Kim KH, Jun DW, Kim CS, Kang KA.
PMID: 41230086 [PubMed - indexed for MEDLINE]


Protein and Macronutrient Metabolism in Liver Cirrhosis: About Sarcopenia.
Nutrients
Han SK, Baik SK, Kim MY.
PMID: 41228421 [PubMed - indexed for MEDLINE]


Thrombotic Risk and Coagulation Imbalance in Cirrhosis and Hepatocellular Carcinoma: Clinical Implications and Management.
Cancers (Basel)
Stella L, De Siati M, Talerico R, Pallozzi M, Cerrito L, Sorrentino S, Gasbarrini A, De Candia E, Pola R, Ponziani FR.
PMID: 41228207 [PubMed]


Machine Learning-Based Prediction of Decompensation in Hepatitis B Virus-Related Cirrhosis.
Diagnostics (Basel)
Lin HC, Hsieh ML, Liu MY, Kuo CC, Shieh SH, Hsieh MS, Hsieh VC.
PMID: 41226084 [PubMed]


Comparative analysis of autophagy and apoptosis pathways in viral and alcoholic cirrhosis: An immunohistochemical study.
Saudi Med J
Demircan G, Berk S, Karayilan D, Ozgur BT, Ketenci S, Elbegi I, Karpuz V, Yavuz M, Midi A, Akin D.
PMID: 41224351 [PubMed - indexed for MEDLINE]


Transcriptomic and experimental evidence confirm the potential of disulfidptosis-related signature for the early diagnosis and treatment of liver cirrhosis.
PLoS One
Liu Y, Zhang R, Sun X, Cui W, Liu L.
PMID: 41223189 [PubMed - indexed for MEDLINE]


Ruminococcus Gnavus Infection Detected in Ascites Fluid in a Patient with Cirrhosis.
Clin Lab
Xie Y, Wang X, Yan X, Yin X, Xu C, Zhang T, Wang X, Du F, Wang X, Wang Y.
PMID: 41221748 [PubMed - indexed for MEDLINE]


Future Management of Sepsis in Liver Cirrhosis.
J Clin Exp Hepatol
Jain A, Singh S, Maiwall R.
PMID: 41216590 [PubMed]


Assessing the Accuracy of Contrast-Enhanced CT Abdomen in Identifying and Stratifying Risk of Oesophageal Varices in Cirrhotic Patients: A Retrospective Study.
Cureus
Collins HJ, Chitturi S, Sharma S, Jain T.
PMID: 41216058 [PubMed]


Liver Maximum Capacity (LiMAx) Test Is a Promising Tool to Predict Fibrosis and Cirrhosis in Chronic Liver Disease: A Systematic Review.
Cureus
Joshi A, Patel E.
PMID: 41216046 [PubMed]


Tolvaptan versus other interventions for hyponatraemia in people with cirrhosis.
Cochrane Database Syst Rev
Anila KN, Saraswathy NS, Mohamed ZU, Varghese CT, Binoj ST, Gopalakrishnan U, Balakrishnan D, Valsan A, Sudhindran S.
PMID: 41211728 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 37175    Seite 1 von 1859  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

  Zeitfenster  
   

Ironmedline

Das Fachportal für Eisenmangel >>

 

Sky right 1